Delivery Order SPE2DB25D3020-SPE2DB25FWKPC
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,135.26 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,720.92 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 mg tablets (30-count supply) on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply agreements with DLA. The medication will be delivered to the company's corporate office location...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,841.66 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is a part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $12,440.35 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This contract has an ultimate completion date of December 10, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly to military treatment facilities, veterans'...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $28,136.54 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,619.32 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (90-count package), with a completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $34,374.97 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count units) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed price, non-set-aside contract represents a routine pharmaceutical procurement executed under competitive procedures. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical supplier for federal...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $29,045.67 to AmerisourceBergen Drug Corp for Myrbetriq ER 50 mg tablets (90-count supply) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $2,416.29 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a prescription medication. This delivery order was placed under an Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for a wide range of medical commodities to...